Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
feature1
New Study: Robot-Assisted Hysterectomy Offers Similar (But Pricier) Results Compared to Laparoscopic Counterpart
According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
VectraCor Cuts to the Heart of Cardiac Symptoms
According to the American Heart Association, approximately 325,000 people per year die of a heart attack before they can reach a hospital.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Cardiogenesis Breaks Ground on Heart-Pumping New Research
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
NeoVista’s Macular Degeneration Device Improves Visual Acuity in Yearlong Study
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.
China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
PAD Awareness Month Brings Often-Overlooked Cardiovascular Disease to the Forefront
While most people are familiar with the big-name heart problems such as cardiac arrest and congestive heart failure, PAD is often overlooked.
NeoChord Device Could Herald New Approach to Mitral Valve Repair
Approximately 250,000 new diagnoses of MR are made each year, but only about 50,000 patients undergo surgery to fix the problem.
S.E.A. Medical Developing Next Generation Prototype for IV Error Prevention
A recent study commissioned by the Society of Actuaries and completed by Milliman, Inc., highlighted both the high personal and financial costs exacted by measurable medical errors.